Utilizing Multimodal Network-Driven Biomarker Discovery for Alzheimer’s Disease Diagnosis & Monitoring
Time: 12:20 pm
day: Day 2 Track A AM
Details:
- Building modules of co-expressing proteins linked to various biological functions, organelles and specific cell types to facilitate network-driven biomarker discovery
- Identifying novel proteomic alterations to help in deeper understanding of disease heterogeneity and pathophysiology of neurodegeneration
- Developing biomarker signature(s) to facilitate clinical management of Alzheimer’s disease through precise disease staging and prediction of disease progression, response to treatment, and adverse effects.
